Scholarlink

Purpose <p>This study aims to compare and organize recommendations from the most eminent international guidelines on the staging and treatment of lymph node (LN) involvement in penile cancer (PC). Early recognition and appropriate management of nodal disease remain the cornerstone of care, influencing both survival and treatment-related morbidity.</p> Methods <p>This study compares and organize recommendations form the most eminent international guidelines—including NCCN, ESMO-EURACAN, and EAU-ASCO—on the staging and treatment of lymph node involvement in penile cancer.</p> Results <p>Open inguinal LN dissection (ILND) remains the standard treatment for not superficial cancers and its morbidity has driven interest in minimally invasive surgical approaches, such as video-endoscopic inguinal lymphadenectomy (VEIL), including its robot-assisted variant (RA-VEIL). Their role is well defined in clinically node-negative (cN0) patients but remains investigational in node-positive (cN+) cases. For cN3 disease and pelvic node involvement, multimodal strategies including chemotherapy, surgery, and radiotherapy are required.</p> Conclusion <p>The variability among guidelines underscores the need for collaborative efforts and high-quality prospective trials to refine and standardize treatment recommendations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Penile cancer and lymph node management: a call for standardization

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月19日

查看全文
  • Achille Aveta,
  • Vincenzo Iossa,
  • Gianluca Spena,
  • Roberto Contieri,
  • Alessandro Izzo,
  • Francesco Passaro,
  • Antonio Tufano,
  • Vittorio Imperatore,
  • Sisto Perdonà,
  • Lorenzo Romano,
  • Carlo Giulioni,
  • Angelo Cafarelli,
  • Pierluigi Russo,
  • Fabio Crocerossa,
  • Francesco Lasorsa,
  • Giuseppe Lucarelli,
  • Matteo Ferro,
  • Raffaele Balsamo,
  • Celeste Manfredi,
  • Davide Arcaniolo,
  • Salvatore Siracusano,
  • Savio Domenico Pandolfo

摘要

Purpose

This study aims to compare and organize recommendations from the most eminent international guidelines on the staging and treatment of lymph node (LN) involvement in penile cancer (PC). Early recognition and appropriate management of nodal disease remain the cornerstone of care, influencing both survival and treatment-related morbidity.

Methods

This study compares and organize recommendations form the most eminent international guidelines—including NCCN, ESMO-EURACAN, and EAU-ASCO—on the staging and treatment of lymph node involvement in penile cancer.

Results

Open inguinal LN dissection (ILND) remains the standard treatment for not superficial cancers and its morbidity has driven interest in minimally invasive surgical approaches, such as video-endoscopic inguinal lymphadenectomy (VEIL), including its robot-assisted variant (RA-VEIL). Their role is well defined in clinically node-negative (cN0) patients but remains investigational in node-positive (cN+) cases. For cN3 disease and pelvic node involvement, multimodal strategies including chemotherapy, surgery, and radiotherapy are required.

Conclusion

The variability among guidelines underscores the need for collaborative efforts and high-quality prospective trials to refine and standardize treatment recommendations.